| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.067 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |